Prenatal Nutrient and Medication Exposures: Neurodevelopmental Risks
Abstract
This review examines potential interactions between common prenatal exposures—including dietary patterns, supplement formulations, over-the-counter medications, and their combined metabolic effects—that may influence fetal neurodevelopment. Specifically, it analyzes how high calcium and iron intake, low magnesium status, synthetic vitamin formulations (folic acid and cyanocobalamin), antacid use, and acetaminophen consumption might interact through shared biochemical pathways. The document provides: - Mechanistic analysis of nutrient-drug interactions affecting maternal and fetal metabolism - Detailed examination of disrupted biochemical pathways including folate-methionine cycling, oxidative stress, and mineral homeostasis - Summary tables of key interactions and their potential neurodevelopmental consequences - Review of current epidemiological evidence linking these exposures to autism spectrum disorder (ASD) and other neurodevelopmental outcomes - Identification of critical research gaps and priorities for future investigation While prenatal vitamins and common medications are generally considered safe, this analysis suggests that their combined effects on one-carbon metabolism, glutathione systems, and calcium-magnesium balance warrant closer scientific scrutiny. The review is intended for researchers, healthcare providers, and public health officials interested in prenatal determinants of neurodevelopmental health. Key findings highlight the need for prospective studies measuring maternal nutrient biomarkers alongside medication use and child neurodevelopmental outcomes. Such research could inform evidence-based prenatal guidelines and potentially reduce neurodevelopmental risk at the population level. This work synthesizes publicly available peer-reviewed literature, NIH/CDC reports, and mechanistic studies. It acknowledges current evidence limitations while providing a framework for hypothesis-driven research into prenatal nutrition and medication safety.
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 6 January 2026